# EMCITATE
> **NDA220963** · New Drug Application · Sponsor: RARE THYROID THERAPEUTICS INTERNATIONAL AB · Approved 2026-09-28
## Drug
- **FDA Application Number:** NDA220963
- **Application type:** New Drug Application
- **Brand name:** EMCITATE
- **Generic name:** Tiratricol
- **Active ingredients:** TIRATRICOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RARE THYROID THERAPEUTICS INTERNATIONAL AB
- **First approval:** 2026-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220963)
---
*MORVS · CC0 1.0*